Aurora Cannabis (NASDAQ:ACB - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by ($0.04), Zacks reports. Aurora Cannabis had a net margin of 1.32% and a return on equity of 0.13%. The business had revenue of $63.34 million during the quarter, compared to analyst estimates of $88.85 million.
Aurora Cannabis Trading Down 12.8%
Shares of ACB traded down $0.60 during trading hours on Friday, hitting $4.08. 4,791,966 shares of the stock were exchanged, compared to its average volume of 1,558,182. Aurora Cannabis has a fifty-two week low of $3.42 and a fifty-two week high of $7.20. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.30 and a quick ratio of 1.60. The business has a 50-day moving average of $5.06 and a 200-day moving average of $4.74. The firm has a market capitalization of $229.34 million, a P/E ratio of 37.09 and a beta of 1.82.
Institutional Investors Weigh In On Aurora Cannabis
An institutional investor recently raised its position in Aurora Cannabis stock. Goldman Sachs Group Inc. lifted its position in shares of Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) by 4.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 743,903 shares of the company's stock after buying an additional 29,099 shares during the quarter. Goldman Sachs Group Inc. owned about 1.32% of Aurora Cannabis worth $3,266,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 47.63% of the company's stock.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access